Paradigm Diagnostics
Phoenix
About Paradigm Diagnostics
Paradigm brings cutting-edge diagnostics and biomarker driven clinical trials to benefit cancer patients.Through Next-Gen Sequencing, and other biomarker analysis, Paradigm is able to provide information about the genomic and proteomic landscape of a patient’s cancer, as well as potential therapies based on the specific characterization of the patient’s tumor; thus, personalizing each patient’s course of treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $23.9M
- Funding stage: M&A
- Last round: Series B (May 2019)
- Website: paradigmdx.com
- Phone: 844.232.4719
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/paradigm-diagnostics-23797 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.